244 related articles for article (PubMed ID: 18688173)
1. Prolongation of corneal allograft survival by topical application of everolimus in experimental keratoplasty.
Li XQ; Buch G; Otasevic L; Schlickeiser S; Bertelmann E; Pleyer U
Ophthalmic Res; 2008 Oct; 40(6):309-14. PubMed ID: 18688173
[TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
3. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
[TBL] [Abstract][Full Text] [Related]
4. Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model.
Pleyer U; Milani JK; Dukes A; Chou J; Lutz S; Rückert D; Thiel HJ; Mondino BJ
Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):52-61. PubMed ID: 7822159
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
6. Effects of a selective glucocorticoid receptor agonist on experimental keratoplasty.
Pleyer U; Yang J; Knapp S; Schäcke H; Schmees N; Orlic N; Otasevic L; De Ruijter M; Ritter T; Keipert S
Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):450-5. PubMed ID: 15821926
[TBL] [Abstract][Full Text] [Related]
7. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment.
Torres PF; Slegers TP; Peek R; van Rooijen N; van der Gaag R; Kijlstra A; de Vos AF
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3194-201. PubMed ID: 10586942
[TBL] [Abstract][Full Text] [Related]
8. Promotion of corneal allograft survival with leflunomide.
Niederkorn JY; Lang LS; Ross J; Mellon J; Robertson SM
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3783-5. PubMed ID: 8088966
[TBL] [Abstract][Full Text] [Related]
9. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
10. Local overexpression of nerve growth factor in rat corneal transplants improves allograft survival.
Gong N; Pleyer U; Vogt K; Anegon I; Flügel A; Volk HD; Ritter T
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1043-52. PubMed ID: 17325145
[TBL] [Abstract][Full Text] [Related]
11. Survival of corneal allografts following topical treatment with the immunomodulator mycophenolate mofetil.
Bertelmann E; de Ruijter M; Gong N; Knapp S; Pleyer U
Ophthalmologica; 2010; 224(1):38-41. PubMed ID: 19672124
[TBL] [Abstract][Full Text] [Related]
12. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
Zhang W; Pan Z; Zhai C
Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
[TBL] [Abstract][Full Text] [Related]
14. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
Shi W; Gao H; Xie L; Wang S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
[TBL] [Abstract][Full Text] [Related]
15. [Effects of anti-CD25 monoclonal antibody on the level of cytokines in aqueous humour after rat penetrating keratoplasty].
Gong YB; Lu XH; Ke XY; Zhou J; Yuan W; Tang MF; Luo XY; Cui GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1523-9. PubMed ID: 18819859
[TBL] [Abstract][Full Text] [Related]
16. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
Gao H; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
[TBL] [Abstract][Full Text] [Related]
17. Topical FK-506 prevents experimental corneal allograft rejection.
Mills RA; Jones DB; Winkler CR; Wallace GW; Wilhelmus KR
Cornea; 1995 Mar; 14(2):157-60. PubMed ID: 7538061
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.
Majewski M; Korecka M; Joergensen J; Fields L; Kossev P; Schuler W; Shaw L; Wasik MA
Transplantation; 2003 May; 75(10):1710-7. PubMed ID: 12777861
[TBL] [Abstract][Full Text] [Related]
19. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
20. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats].
Lü L; Zhang W; Sun X
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):25-8. PubMed ID: 11835769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
